OpenVSafe by OpenVAERS
Search V-safe

HZA-12659-96194

1 vaccination 2 coded responses 8 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
497 / MI
Registered
2022-07-31
Relationship
Child or adolescent in my care
Guardian
XUA-21249-54893
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-29
    Dose 1 — Moderna
  2. 2022-07-31
    Registered in v-safe
  3. 2022-07-31
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to do your normal daily activities
    Under 3 check-in
  4. 2022-08-01
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Under 3 check-in
  5. 2022-08-01
    Report sent to call center — days 1–6 daily, dose 1, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  6. 2022-08-02
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Sleepiness, Irritability/crying · Be unable to work or attend school
    Under 3 check-in
  7. 2022-08-02
  8. 2022-08-07
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-08-14
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  10. 2022-08-19
    Survey response — day 21, dose 1, under 3
    MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school
    Free text: Congested and cough
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-09-11
    Health check-in — day 42, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-10-30
    Survey response — 3 months, dose 1, under 3
    MedDRA: Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: RSV
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-10-30
    Report sent to call center — 3 months, dose 1, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  14. 2022-10-31
  15. 2022-10-31

Vaccinations

DoseDateManufacturerCo-administered
12022-07-29Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2022-08-01 Unsuccessful
2022-10-30 Unsuccessful

Free text

Release 12 (Under 3) — day 21, dose 1, under 3

2022-08-19

Symptoms: Congested and cough

Release 12 (Under 3) — 3 months, dose 1, under 3

2022-10-30

Symptoms: RSV

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDRespiratory syncytial virus infection · · ✓
SDRespiratory tract congestion · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…